googleads

Global Bovine Respiratory Disease Treatment 2017-2021

  • Published: Mar 2017
  • Pages: 70
  • SKU: IRTNTR11687
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version!

Bovine respiratory disease treatment market value

According to Technavio’s analyst, the global BRD treatment market is anticipated to grow at a steady rate and will post a CAGR of more than 8% during the forecast period. The development of novel products and launch of new products will increase the adoption rates and drive the growth prospects for the global bovine respiratory disease (BRD) treatment market until the end of 2021. One of the major factors responsible for the market's growth is the increasing interests of several vendors on the development of novel drugs to gain a competitive advantage over their competitors. For instance, Bayer HealthCare launched Zelnate in the US, which is a bacterial-produced plasmid DNA including a liposome carrier that helps to stimulate the innate immune system in cattle. Furthermore, under traditional antibiotics segment also, vendors are launching various drugs such as draxxin for the cattle respiratory disease treatment.

Get A Free Sample

Table of Contents

PART 01: Executive summary

PART 02: Scope of  the report

PART 03: Research Methodology

PART 04: Introduction

  • Key market highlights

PART 05: An overview of bovine respiratory disease

PART 06: Market landscape

  • Market overview
  • Five forces analysis

PART 07: Market segmentation by product category

  • Antibiotics
  • Vaccines
  • Others

PART 08: Geographical segmentation

  • BRD vaccine market in Americas
  • BRD treatment market in EMEA
  • BRD treatment market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments

PART 11: Market trends

  • Growing focus on the development of combination drugs
  • Increase in preventive measures
  • Advancements in technology

PART 12: Vendor landscape

  • Competitive scenario

PART 13: Key vendor analysis

  • Bayer HealthCare
  • Boehringer Ingelheim
  • Elanco
  • Merck
  • Zoetis
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

Tags: veterinary care, animal care, dna vaccine, medical companies, healthcare industry trends, healthcare market study,

Safe and Secure SSL Encrypted
Technavio
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

*For Enterprise license, go to checkout page

*Avail subscription at 50% off, with report purchase - limited to a week

  • 2500 USD


[5 reports/month/user]

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

  • 5000 USD

Quick BuyTechnavio
View Free Data Sample
VIEW FREE SAMPLE PDF

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights